Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries
暂无分享,去创建一个
M. Ezzati | K. Kuntz | C. Kong | Jennifer M Yeh | C. Hur | S. Goldie | Jennifer M. Yeh | J. Yeh
[1] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[2] P. Correa,et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. , 1976, Journal of the National Cancer Institute.
[3] III. Natural history of precursor lesions. , 1976 .
[4] R. Peto,et al. Diet life-style and mortality in China: a study of the characteristics of 65 Chinese counties. , 1990 .
[5] E. Fontham,et al. Gastric precancerous process in a high risk population: cohort follow-up. , 1990, Cancer research.
[6] E. Fontham,et al. Gastric precancerous process in a high risk population: cross-sectional studies. , 1990, Cancer research.
[7] H. Adami,et al. Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. , 1991, British Journal of Cancer.
[8] P. Sipponen,et al. The Sydney System: Epidemiology and natural history of chronic gastritis , 1991, Journal of Gastroenterology and Hepatology.
[9] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[10] J. Fraumeni,et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. , 1992, Journal of the National Cancer Institute.
[11] W. Blot,et al. Precancerous gastric lesions in a population at high risk of stomach cancer. , 1993, Cancer research.
[12] C. Pusey,et al. Long-term sequelae of Helicobacter pylori gastritis , 1995, The Lancet.
[13] L. Irwig,et al. Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. , 1996, The American journal of gastroenterology.
[14] P. Sipponen,et al. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. , 1996, Scandinavian journal of gastroenterology.
[15] N. Talley,et al. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. , 1997, The American journal of gastroenterology.
[16] M. Gail,et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. , 1998, International journal of epidemiology.
[17] M. Gail,et al. Helicobacter pylori infection and mode of transmission in a population at high risk of stomach cancer. , 1998, International journal of epidemiology.
[18] P. Malfertheiner,et al. Diagnosis of Helicobacter pylori infection with a new non-in vasive antigen-based assay , 1999, The Lancet.
[19] M. Gail,et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer , 1999, International journal of cancer.
[20] P. Malfertheiner,et al. Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. , 1999, Lancet.
[21] M. Blaser,et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. , 2000, Journal of the National Cancer Institute.
[22] L. Tabár,et al. Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases , 2000, Biometrics.
[23] M. Gail,et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.
[24] M. Corrao. Tobacco control country profiles , 2000 .
[25] Sigrún Andradóttir,et al. Applying Bayesian ideas in simulation , 2000, Simul. Pract. Theory.
[26] A. Helicobacter,et al. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts , 2001, Gut.
[27] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[28] A. O'Hagan,et al. Bayesian calibration of computer models , 2001 .
[29] M. Gail,et al. Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.
[30] D. Roder,et al. The epidemiology of gastric cancer , 2002, Gastric Cancer.
[31] Milton C Weinstein,et al. Empirically calibrated model of hepatitis C virus infection in the United States. , 2002, American journal of epidemiology.
[32] M. Sanaka,et al. Ten‐year prospective follow‐up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings , 2002, Alimentary pharmacology & therapeutics.
[33] D. Forman. Results of intervention trials in Helicobacter pylori -infected populations , 2003 .
[34] J. Guarner,et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. , 2003, Human pathology.
[35] [Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis]. , 2003, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[36] D. Parkin. International variation , 2004, Oncogene.
[37] M. Ezzati. How can cross-country research on health risks strengthen interventions? Lessons from INTERHEART , 2004, The Lancet.
[38] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[39] J. Gisbert. The Recurrence of Helicobacter pylori Infection: Incidence and Variables Influencing It. A Critical Review , 2005, The American Journal of Gastroenterology.
[40] M. Gail,et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.
[41] Vipat Kuruchittham,et al. The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.
[42] Amy Ming-Fang Yen,et al. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer. , 2006, Journal of medical screening.
[43] Natasha K. Stout,et al. Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .
[44] Jeremy D Goldhaber-Fiebert,et al. Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. , 2006, Vaccine.
[45] Karen M Kuntz,et al. Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.
[46] Zaim Gashi,et al. Helicobacter pylori infection and precancerous lesions of the stomach. , 2010, Medicinski arhiv.